Linked

SciClone Pharmaceuticals

Website http://www.sciclone.com/
Location San Francisco
Industry Healthcare & Pharmaceuticals
Revenue unknown
Investment unknown
Growth unknown
Employees unknown

SciClone Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases. Our strategy is to in-license late-stage clinical products and develop them for commercialization in the United States, Europe, and China, one of the worldís fastest growing pharmaceutical markets.

Our lead product ZADAXINÆ, our brand of thymalfasin, is one of the largest selling imported drugs in China today based on revenues, and ZADAXIN also is approved in several other promising international markets. For the U.S. and Europe, we are evaluating thymalfasin in a nearly completed phase 3 trial for the hepatitis C virus (HCV) and a planned phase 3 trial for malignant melanoma. For the U.S., we are conducting a phase 2 HCV trial for SCV-07 and a phase 2 pancreatic cancer trial for RP101.

(Source: SciClone Pharmaceuticals)

Categorize SciClone Pharmaceuticals

Add a short phrase/word that describes
this company

Contact Information

950 Tower Lane
Suite 900
Foster City, CA 94404
Corporate Phone: (650) 358-3456



Similar Companies